re: clinical trials28 Jul 2017 01:00
Need a great set of results but the bigger picture is needed to understand why the monoclonal antibody wasn't as effective as expected. Often the issue are about delivery to what is a multilayered solid tumour and harder to treat especially when metastatic. These are exciting times and given the complexity of the science there will always be set backs. GLA DYOR